Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under Alto Neuroscience, Inc. in our court records and SEC 8-K records (as of 2026-10-18).
- Leadership changes: the latest reported is Nicholas C. Smith, Chief Financial Officer and Chief Business Officer (Form 8-K filed 2026-08-27). Check you are dealing with the people now in charge.
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Sirenia Capital Management LP (filed 2026-08-14).
Who is behind it
Alto Neuroscience, Inc.: incorporated in Delaware; business address in Mountain View, California; industry Pharmaceutical Preparations (Form D, 2026-08-27).
Officers and directors, each with the role and the filing that names them:
- Amit Etkin: Executive Officer, Director (Form D, 2025-10-27)
- Michael Hanley: Executive Officer (Form D, 2025-10-27)
- Adam Savitz: Executive Officer (Form D, 2025-10-27)
- Nicholas C. Smith: Executive Officer (Form D, 2025-10-27)
- Gwill York: Director (Form D, 2025-10-27)
- Christopher Nixon Cox: Director (Form D, 2025-10-27)
- Andrew Dreyfus: Director (Form D, 2025-10-27)
- Husseini Manji: Director (Form D, 2025-10-27)
- Raymond Sanchez: Director (Form D, 2025-10-27)
| Report | Holder | Share |
|---|---|---|
| Schedule 13G/A, 2026-08-14 | Sirenia Capital Management LP | 6.2% |
| Schedule 13G/A, 2026-08-14 | Vestal Point Capital, LP | 2.2% |
| Schedule 13G/A, 2026-08-14 | Perceptive Advisors LLC | 9.99% |
| Schedule 13G, 2026-07-27 | Blackrock, Inc. | 6% |
| Schedule 13G, 2026-07-20 | Ecor1 Capital, LLC | 5.8% |
| Schedule 13G, 2026-05-15 | Sirenia Capital Management LP | 7.9% |
| Schedule 13G/A, 2026-05-15 | Vestal Point Capital, LP | 6.5% |
| Schedule 13G/A, 2026-05-15 | Steven A. Cohen | 3.7% |
| Filed | Person | Role | Change | Effective |
|---|---|---|---|---|
| Form 8-K, 2026-08-27 | Nicholas C. Smith | Chief Financial Officer and Chief Business Officer | appointed | |
| Form 8-K, 2026-05-28 | Andrew Miller | Director | appointed | |
| Form 8-K, 2026-05-28 | Andrew Miller | appointed |
Money raised
| Filed | Sold | Offered |
|---|---|---|
| Form D, 2025-10-27 | $50M | $50M |
| Form D, 2023-11-27 | $7.72M | $7.72M |
| Form D, 2023-11-27 | $59.26M | $59.26M |
| Form D, 2023-11-27 | $45M | $45M |
| Form D, 2023-11-27 | $31.89M | $31.89M |
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
Permanent URL:
https://mentionfox.com/who-owns/alto-neuroscienceLast updated 2026-10-18
Primary record: Schedule 13G/A, 2026-08-14 · Form D, 2025-10-27 · Form 8-K, 2026-08-27 · Form 8-K, 2026-05-28
Who owns Alto Neuroscience, Inc.? Owners, funding and legal record. MentionFox, 2026-10-18. https://mentionfox.com/who-owns/alto-neuroscience